Clin2
NCT06777732Likely a fitNot yet recruiting

Testing a new medicine for clearing H. pylori stomach infection

Helicobacter Pylori Infection

Treatments studied

Part of Digestive system clinical trials.

This study tests a new medicine called Keverprazan, which may help get rid of the H. pylori bacteria that causes stomach ulcers and other problems. If you have H. pylori and haven't been treated before, this trial could help you clear the infection with a new approach.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
672 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You tested positive for H. pylori on a breath test and have never been treated for it before.
  • You are not allergic to penicillin or other antibiotics used in the study.
  • You have not had stomach or intestinal bleeding in the last 4 weeks.
  • You have not taken certain antibiotics, bismuth, or acid-reducing pills recently.
  • You are not pregnant or breastfeeding, and you do not have serious health conditions like cancer or liver/kidney disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07624422Not yet recruiting· Phase 4
Helicobacter pylori infection treatment study

This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.

Damascus
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT07242456Recruiting· Phase 2/Phase 3
Comparing two treatments for H. pylori infection

This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.

Hangzhou, Zhejiang
NCT07122024Recruiting· Phase 4
Testing a dual therapy for H. pylori treatment

This trial tests a two-drug treatment (keverprazan and amoxicillin) for people who have H. pylori and have not been treated for it before. The goal is to see if this newer combination works well and is safe.

Hangzhou, Zhejiang
NCT07750938Not yet recruiting· Phase 4
Better acid control for first-time H. pylori treatment

This study tests a new combination of medicines to treat H. pylori, a stomach infection that can cause ulcers. It aims to see if stronger acid suppression helps the antibiotics work better and clear the infection.

NCT06734260Recruiting· Phase 3
Optimizing a two-drug therapy for H. pylori infection

This trial tests a two-drug combination (keverprazan and amoxicillin) to see if it works better for treating H. pylori, a bacteria that can cause stomach problems. It is for people who have had H. pylori before and need treatment again.

Guangzhou, Guangdong

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.